Muna son saita ƙarin kukis don fahimtar yadda kuke amfani da GOV.UK, tuna saitunanku da haɓaka ayyukan gwamnati.
Sai dai in an lura da haka, ana rarraba wannan ɗaba'ar ƙarƙashin Buɗaɗɗen lasisin Gwamnati v3.0.Don duba wannan lasisi, ziyarci nationalarchives.gov.uk/doc/open-government-licence/version/3 ko rubuta zuwa ga Manufofin Bayani, The National Archives, Kew, London TW9 4DU, ko imel: psi@nationalarchives.gov.UNITED MULKIN.
Idan mun san kowane bayanin haƙƙin mallaka na ɓangare na uku, kuna buƙatar samun izini daga mai haƙƙin mallaka.
Ana samun littafin a https://www.gov.uk/government/publications/uknhcc-scientific-opinion-white-mulberry-leaf-extract-and-blood-glucose-levels/scientific-opinion-for-the-substantiation .samun-da'awar-na-lafiya-kan-bangare-daya-daga-farin-mulberry-haskar-da-taimako-lafiya-bl
Ka'idar da'ar UKNHCC ta bayyana cewa masu sa ido a hukumance suna halartar tarukan UKNHCC don samar da sabbin bayanai kan al'amuran kimiyya da manufofin kasashensu tare da mutunta 'yancin kai na UKNHCC.
UKNHCC (Majalisar Kula da Abinci da Lafiya ta Burtaniya), 2023 Tsararriyar Ra'ayin Kimiyya (EC) No 1924/2006, Dokokin Gina Jiki (gyara da dai sauransu) (Barin EU) da Dokokin Abinci (gyara da dai sauransu) .) (fitarwa daga EU) 2020 kamar yadda aka gyara.
Wannan ra'ayi ba shine kuma bai kamata a fassara shi azaman izinin tallace-tallace don tsantsar ganyen Mulberry ba, ingantaccen kimanta lafiyarsa, kuma ba hukunci bane akan ko an rarraba tsantsar ganyen Mulberry azaman kayan abinci.Ya kamata a lura cewa ba a ba da wannan nau'in ƙa'idar ba a ƙarƙashin Abinci (gyara, da dai sauransu) (Barin EU) Dokar 2019 da Dokar Kula da Abinci (gyara) (EC) No 1924/2006 [labari na 1], da sauransu. .) (Fita daga EU) Dokokin 2020
Har ila yau, ya kamata a jaddada cewa iyakokin, maganganun da aka ba da shawara na da'awar da kuma yanayin amfani da mai nema ya gabatar na iya canzawa kafin kammala tsarin bayar da kyauta da aka tanadar a cikin Mataki na 18 (4) na Dokar Taimako (EC). Babu 1924/2006 [bayanin kula na 1] Kamar yadda aka gyara, ta Abinci (gyara, da sauransu) (Barin EU) Dokokin 2019 da Abinci (gyara, da sauransu) (Barin EU) Dokokin 2020.
UKNHCC ta karɓi aikace-aikacen akan 5 ga Agusta 2022 kuma an fara aiwatar da aikin tantancewar kimiyya nan da nan.
A ranar 19 ga Agusta, 2022, an dakatar da kimantawar kimiyya bayan tsarin “tsayawa agogo” da ke buƙatar masu neman su ba da ƙarin bayani.
A ranar 4 ga Satumba 2022, UKNHCC ta sami ƙarin bayani kuma ta sake ƙaddamar da kimar kimiyya daidai da Mataki na 16(1) na Doka (EC) No 1924/2006.
Izinin yin da'awar kiwon lafiya a ƙarƙashin Mataki na 14 (1) (a) Dokokin Rayuwa (EC) No 1924/20061 kamar yadda aka gyara ta hanyar Nutrition (gyara, da dai sauransu) Dokokin (fitarwa daga Tarayyar Turai) 2019 kuma hukumar da ta dace ta Burtaniya ta bayar. .Hukuma akan aikace-aikacen Ascarit UK.A cikin Tsarin Gina Jiki (gyara, da dai sauransu) (Barin EU) Dokokin 2020, an nemi Kwamitin Kula da Abinci da Lafiya na Burtaniya (UKNHCC) don yin sharhi kan tushen kimiyya don da'awar lafiyar ganyen Mulberry (M. alba).Abubuwan da aka samo "an tabbatar da su a asibiti don taimakawa kula da matakan sukari na jini."
An ba da shawarar cewa iyakar aikace-aikacen ta kasance ƙarƙashin buƙatun kiwon lafiya masu alaƙa da rage haɗarin cututtuka, gami da buƙatar kariya ta sirri, wanda aka janye daga baya.
Samfurin sinadirai da ake da'awar cewa yana da koshin lafiya, wani sashi ne na ganyen M. alba (farin mulberry).
A ra'ayin kwamitin, tsantsar abinci mai gina jiki na ganyen M. alba bai isa ya siffanta da'awar da aka gabatar ba.
Da'awar mai nema shine cewa cirewar ganyen M. alba "an tabbatar da shi a asibiti don taimakawa kula da matakan sukarin jini lafiya."Abinda ke haifar da haɗari shine haɓakar sukarin jini kuma haɗarin haɗarin haɗari shine nau'in ciwon sukari na 2.Rukunin da aka yi niyya shine "marasa lafiya da nau'in ciwon sukari na 2".Irin waɗannan tasirin da ake da'awar sun yi waje da iyakokin Mataki na 14 (1) (a) da'awar lafiya.Kamar yadda aka ayyana a cikin Mataki na 2 (6) na Doka (EC) No 1924/2006, "da'awar rage haɗarin cuta" ita ce duk wata da'awar kiwon lafiya da ta faɗi, ba da shawarar ko nuna amfani da nau'in abinci, abinci ko ɗaya daga cikin abubuwan da ke tattare da shi.Mahimman rage abubuwan haɗari ga ci gaban cututtukan ɗan adam.A cewar Cibiyar Abinci, Gina Jiki da Allergy (NDA) na Hukumar Kula da Kare Abinci ta Turai (EFSA), Hukumar ta yi imanin cewa da'awar kiwon lafiya ya kamata ta koma ga yawan jama'a (lafiya).Kwamitin ya kuma yi la'akari da cewa idan da'awar kiwon lafiya ta shafi aiki ko tasiri da za a iya dangantawa da cuta, batutuwa masu cutar ba su ne adadin yawan jama'a da ake nufi da da'awar (EFSA, 2021).
Kwamitin bai san tsarin da aka yi amfani da shi a cikin nazarin wallafe-wallafen da mai nema ya gabatar ba don haka ba zai iya tantance ko an gabatar da duk shaidun don la'akari ba.Mai neman ya gano jimillar wallafe-wallafe 13 da ya yi imanin sun dace da da'awar, gami da:
Daga cikin shaidar da Mai nema ya bayar, 2 RCTs (Lown et al. 2017; Thondre et al. 2021) ba su kimanta shaidar da ke goyan bayan wannan da'awar ba.Gwajin sarrafa bazuwar (Mudra et al., 2007) wani rahoto ne na taƙaitaccen bayani kuma an yi la'akari da shi yana da babban haɗari na son zuciya.Wani binciken da ba a sarrafa shi ba (Chatterji da Fogel, 2018) bai kimanta shaida don tallafawa wannan da'awar ba.Littattafai biyar (Bensky, 1993; Asano et al., 2001; Saudek et al., 2008; Gomyo et al., 2004; NIH, 2008) ba su bayar da rahoton kayayyakin abinci da/ko da'awar tasirin ba.Littattafai uku (Lown, 2017; Drugs.com, 2022; Gordon-Seymour, 2021) wallafe-wallafen marasa ilimi ne.Ɗaya daga cikin wallafe-wallafe (Thaipitakwong et al., 2018) wani labarin bita ne akan ganyen mulberry da yuwuwar tasirin su akan haɗarin cardiometabolic.A ra'ayin kwamitin, ba za a iya yanke shawara daga waɗannan wallafe-wallafen don tallafawa wannan ikirari ba.
Dangane da bayanin da aka bayar, Kwamitin ya kammala da cewa ba za a iya kafa alaƙar da ke tsakanin shan leaf ɗin M. alba da kuma tasirin da ake da'awar ba.Kwamitin ya kuma yanke shawarar cewa babu wata shaida da aka bayar na alaƙa tsakanin abubuwan da ake da'awar da kuma haɗarin kamuwa da ciwon sukari na 2.
Aikace-aikacen ya ƙunshi buƙata don kare bayanan sirri, wanda aka cire daga baya.
Abincin da ya kasance batun da'awar lafiya shine M. alba (farin mulberry), wanda ya kai kashi 50% na abun ciki na roundworm.
Kasancewar mulberry ya rage yawan adadin glucose daga matakin sarrafawa zuwa matakin ƙasa kuma yana haɓaka matakin insulin sosai idan aka kwatanta da matakin sarrafawa.A cikin binciken asibiti, an gwada zagaye tsutsotsi don ikon su na rage matakan glucose.An gudanar da binciken shiga tsakani na tsakiya guda ɗaya a cikin Isra'ila.
Mai nema ya ba da shawarar waɗannan kalmomi masu zuwa na da'awar fa'idar kiwon lafiya: "An tabbatar da asibiti don taimakawa kula da matakan sukari na jini."
Mai nema bai ba da takamaiman sharuɗɗa don amfani da abincin M. alba wanda shine batun sanarwar ba.An ba da shawarar sharuɗɗan amfani don ƙarin Ascarit.Rukunin da aka yi niyya shine marasa lafiya da ke da nau'in ciwon sukari na 2.
Bisa ga Mataki na 14 (1) (a) na Doka (EC) No 1924/2006 [bayani na 1] Gyara ta hanyar da'awar abinci mai gina jiki (gyara) game da da'awar kiwon lafiya na cire ganyen Mulberry da kiyaye matakan sukarin jini lafiya, da sauransu d.) (Kwantar da EU) Dokokin 2019 da Ka'idodin Abinci (gyara, da sauransu) (Barin EU) Dokokin 2020 ID na aikace-aikacen: 002UKNHCC.Ascarit UK ta gabatar.
1.1 Dangane da buƙatar UKNHCC don fayyace samfurin abinci wanda shine batun da'awar lafiya, mai nema ya tabbatar da cewa samfurin abinci shine tsantsa daga M. alba (farin mulberry leaf).Mai nema bai bayar da cikakkun bayanai kan abun da ke ciki ba, bambancin tsari-zuwa-tsari, ko nazarin kwanciyar hankali na tsantsar leaf M. alba.
1.2 Mai nema ya ba da bayyani game da tsarin masana'antar Ascarite wanda aka bayyana azaman ƙari mai abubuwa da yawa wanda ya ƙunshi:
Ana tsaftace ganye da furanni kuma ana sabunta su (watau riƙe ainihin launi, siffa, da kumburi) ta hanyar haɗuwa da yanke, latsawa, da hakar zafi tare da shayarwa don haɓaka dawo da samfuran shuka, gami da takardar latex.Bayan haka, ruwan yana da sauri sanyaya zuwa 20-30 digiri Celsius, sa'an nan kuma tace.Ana tsaftace tushen da haushi, sannan ana sarrafa su ta amfani da cire zafi da sanyaya.Maganin gauraye ya ƙunshi (a matsayin kashi ta nauyi na jimlar yawan maganin) 50% Morus, 20% Artemisia, 10% Urtica, 10% Cinnamon da 10% Taraxacum.
Mai nema ya bukaci a kiyaye yanayin mallakar kayan aikin Ascarit da tsarin kera, amma daga baya ya janye wannan bukata.
1.3 A cikin ra'ayi na kwamitin, kayan abinci mai gina jiki na ganyen M. alba, wanda shine batun da'awar kiwon lafiya, ba a bayyana shi sosai ba game da abubuwan da aka tsara.
2.1 Mai nema ya bayyana cewa nau'in ciwon sukari na 2 cuta ce ta rayuwa wacce ke da girman matakan glucose na jini.Dangane da buƙatar UKNHCC don shaidar da ke nuna alaƙar da ke tsakanin haɗarin haɗari (maganin glucose na jini) da haɗarin cutar da ke da alaƙa (nau'in ciwon sukari na 2), mai nema ya gabatar da karatun 3 (DCCT, 1995; Rohlfing et al., 2002). ; Sveta, 2014).Dukansu Ƙwararrun Ƙwararrun Ciwon sukari da Ƙwararrun Ƙwararru (DCCT) ƙungiyar nazarin (1995) da Rolfing et al.(2002) ya ruwaito DCCTs ciki har da marasa lafiya masu ciwon sukari masu dogaro da insulin (nau'in 1) amma ba tare da ciwon sukari na 2 ba.nau'in (cutar da ake buƙatar rage haɗarin haɗari).).Swetha (2014) ya ƙididdige ma'amala tsakanin HbA1c (glycosylated haemoglobin) da sakamako daban-daban (azumi, postprandial da glucose na hutawa) don tantance amfanin su don kula da sarrafa glycemic a cikin masu ciwon sukari.A cikin ra'ayi na kwamitin, masu neman ba su ba da shaidar alaƙar da ke da alaƙa tsakanin haɓakar matakan glucose na jini da haɗarin haɓaka nau'in ciwon sukari na 2 ba, ko kuma haɓakar matakan glucose na jini mai zaman kansa ne mai hangen nesa na nau'in ciwon sukari na 2.
2.2 Mai nema ya ba da wasu ƙarin bayani don amsa buƙatar UKNHCC don bayani game da sakamako, sauye-sauyen sakamako da abubuwan da aka tsara don tantance abubuwan haɗari a cikin nazarin ɗan adam.Sai dai kuma bisa ga bayanan da aka bayar, kwamitin bai bayyana wa kwamitin ko wane sakamakon da masu neman za su bayar ba da kuma yadda za a tantance su.
2.3 Tasirin da'awar mai nema "an tabbatar da shi a asibiti don taimakawa kula da matakan sukari na jini".Ƙungiyar da mai nema ya gabatar da ita shine marasa lafiya da ke da nau'in ciwon sukari na 2.
2.4 Kwamitin ya lura cewa ƙungiyar da aka tsara na marasa lafiya tare da nau'in ciwon sukari na 2 ba a ƙarƙashin da'awar kiwon lafiya a ƙarƙashin Mataki na 14 (1) (a) na Dokar (EC) No 1924/2006.Kamar yadda aka ayyana a cikin Mataki na 2 (6) na Doka (EC) No 1924/2006, "da'awar rage haɗarin cuta" ita ce duk wata da'awar kiwon lafiya da ta faɗi, ba da shawarar ko nuna amfani da nau'in abinci, abinci ko ɗaya daga cikin abubuwan da ke tattare da shi.Matsakaicin raguwar abubuwan haɗari don haɓaka cututtukan ɗan adam.A cewar Cibiyar Abinci, Gina Jiki da Allergy (NDA) na Hukumar Kula da Kare Abinci ta Turai (EFSA), Hukumar ta yi imanin cewa da'awar kiwon lafiya ya kamata ta koma ga yawan jama'a (lafiya).Kwamitin ya kuma yi la'akari da cewa idan da'awar kiwon lafiya ta shafi aiki ko tasiri da za a iya dangantawa da cuta, batutuwa masu cutar ba su ne adadin yawan jama'a da ake nufi da da'awar (EFSA, 2021).
2.5 Don cimma sakamakon da'awar, mai nema ya ba da shawarar shan capsules 2 roundworm da ruwa minti 30 kafin abinci sau 3 a rana.Masu neman ba sa ba da shawarar maida hankali, sashi ko tsawon lokacin amfani.
2.6 Kwamitin ya lura cewa raguwa a cikin martanin glycemic na postprandial na iya zama da amfani ga mutanen da suka riga sun sha wahala daga rashin haƙuri na glucose, amma kwamitin ya yi la'akari da cewa kalmomin da aka gabatar ba su cika ka'idodin la'akari ba a cikin Mataki na 14 (1) (a) , kuma ba ta yi bayani kan fa'idodin kiwon lafiya Ma'auni na yawan jama'a waɗanda za a iya yin iƙirarin rage haɗarin cututtuka.
3.1 Lokacin da UKNHCC ta buƙata, ana buƙatar masu nema don ba da cikakkun bayanai game da bitar wallafe-wallafen, gami da mawallafi, maƙasudai, ƙa'idodin cancanta, cikakken dabarun bincike da kowane bincike na bayanai.Bayanin da aka bayar yana da iyaka sosai har kwamitin ya kasa tantance ko an gabatar da duk shaidun don dubawa.
3.2 Mai neman ya gano jimillar wallafe 13 da ya yi imanin sun dace da da'awar, gami da:
Kwamitin ya yi la'akari da cewa ba za a iya yanke shawara daga waɗannan wallafe-wallafen ba saboda babu tabbataccen shaida da ke tabbatar da wannan ikirari.
3.4 Ya ƙunshi hanyar haɗi zuwa littafi kan magungunan gargajiya na kasar Sin (Bensky, 1993).Babu wani bayani babi, lambobin shafi, ko wasu sassa na littafin da aka mika wa kwamitin don tantancewa, don haka ba za a iya tantance su ba.
3.5 Takardun gaskiya (NIH, 2008) ta taƙaita nazarin akan kula da ciwon sukari da rikitarwa da kuma nazarin binciken, amma baya kimanta shaidar da ke goyan bayan wannan da'awar, don haka ba za a iya yanke shawara daga wannan littafin ba.
Wani binciken dakin gwaje-gwaje (Asano et al., 2001) ya bayyana sakin M. alba alkaloids da tasirin hana su akan glycosidases, amma ba a kimanta shaidar da ke tallafawa wannan da'awar ba.Kwamitin ya yi la'akari da cewa ba za a iya yanke shawara daga waɗannan littattafan ba.
3.7 A cikin RCTs guda uku (Low et al., 2017; Thondre et al., 2021; Mudra et al., 2007), mahalarta an ba su da kayyade don karɓar cirewar ganye na Mulberry.Lown et al.(2017) da Thondre et al.(2021) sun kasance makafi sau biyu, bazuwar, matakan maimaitawa, gwaje-gwajen juzu'i da ke kimanta amfani ko rashin amfani da tsantsar leaf na mulberry (Reducose®) tare da placebo a cikin batutuwa masu lafiyayyen martanin glycemic mahalarta ga ƙalubalen carbohydrate.A ra'ayin kwamitin, ba za a iya yanke shawara daga waɗannan wallafe-wallafen ba saboda ba su tantance shaidun da ke goyon bayan wannan ikirari ba.Mudra et al.(2007) wani taƙaitaccen rahoto ne wanda ke taƙaita binciken da aka yi bazuwar crossover wanda yayi la'akari da tasirin mulberry ganye ko placebo akan amsawar glucose na jini na mahalarta lafiya (masu halartar 10) da marasa lafiya da nau'in ciwon sukari na 2 (mutane 10).Kwamitin ya yi la'akari da cewa binciken na iya kasancewa cikin haɗari mai tsanani saboda rashin bayani game da tsarin bazuwar, yuwuwar rashin daidaituwa da ke tattare da shiga tsakani da aka yi niyya, da kuma yiwuwar zabar sakamakon da aka ruwaito.
3.8 Binciken da ba a sarrafa shi ba (Chatterji da Fogel, 2018) ya haɗa da marasa lafiya da nau'in ciwon sukari na 2.Chatterji and Fogel (2018) sun kimanta tasirin kayan lambu na SR2004 (wanda ya ƙunshi ganyen M. alba, ganyen U. dioica, haushin kirfa, tsantsawar ganyen dracunculus da T. officinale tushen tushen) akan matakan HbA1c sau ɗaya a mako don kwanaki 12. .makonni sannan a sati 24.A cikin ra'ayi na kwamitin, ba za a iya yanke shawara daga wannan binciken da ba a kula da shi ba, wanda bai kimanta shaidar da ke goyon bayan da'awar ba.
3.9 Don haka kwamitin ya yi la'akari da cewa ba za a iya yanke shawara ba daga shaidar da mai korafin ya gabatar kan tasirin tsinken ganyen albaflora akan yawan glucose na jini.
4.1 A cikin kimanta shaidar, kwamitin yayi la'akari da 1 bazuwar gwajin gwaji (Mudra et al., 2007) daga abin da za a iya yanke shawara.
4.2 Kwamitin ya yanke shawarar cewa, bisa ga shaidar da aka gabatar, ba zai yiwu a kafa dangantakar da ke da alaka tsakanin amfani da ganyen Albiflora da kuma tasirin da ake da'awar ba.Kwamitin ya kuma yanke shawarar cewa babu wata shaida da aka bayar na alaƙa tsakanin abubuwan da ake da'awar da kuma haɗarin kamuwa da ciwon sukari na 2.
Morus Alba (Muscus alba) Cire Leaf Ba a yi bayanin abin da ake buƙata na da'awar kiwon lafiya ba dangane da abubuwan da ake da'awar.
Da'awar sakamako ga marasa lafiya da ke da nau'in ciwon sukari na 2 ba su cika ka'idodin da aka tsara a cikin Doka (EC) No 1924/2006 ba.daidai da sashe na 14(1)(a).
Ba za a iya kafa alaƙar da ke da alaƙa tsakanin amfani da tsantsar ganyen mulberry da abubuwan da ake da'awa ba, kuma babu wata shaida ta alaƙa tsakanin abubuwan da ake da'awar da kuma haɗarin haɓaka nau'in ciwon sukari na 2.
Lokacin aikawa: Janairu-29-2023